TRIAL MANAGEMENT
Disclosure As A Service ROI
How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.
Navigating Early Phase CNS-Active Drug Development
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating th...
Yes, Your Study Is At Risk: Risk Mitigation Plans For Endpoints
Ocular endpoints often introduce unique bottlenecks that can stall enrollment and compromise data integrity. This presentation provides the tools for a streamlined, resilient clinical trial strategy.
Build Your Diversity Action Plan With AI And Patient Insights
Discover how AI and patient insights can help you build a compliant Diversity Action Plan and overcome barriers to achieve diverse clinical trial enrollment.
Korio RTSM Platform: Dosing Configuration Demo
Protocols evolve — and Korio is built to evolve with them. In this demo, see how users can easily add new doses, configure dose use rules, and define logic for dose adjustments based on visit history or other criteria.
Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements
In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).
Tailored Sponsor Engagement Key To Unlocking Site Network Efficiency
Karri Venn, VP site advocacy and mentorship at SCRS, emphasized the importance of sponsors recognizing the structure and capabilities of larger site networks.
Mastering Scope 3 Emissions In Clinical Trials
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
Practical Approaches To Faster Study Start-Ups
Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.
The Path Forward, Altasciences' Approach To Project Management
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
Defining And Implementing The Right Oncology Digital Strategy
A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.
RTSM Misalignment Hiding In Your Clinical Trial Protocol
Unclear protocol details can quickly create problems across a clinical trial, but bringing in experienced systems thinkers early to identify gaps before they create downstream issues can help.
Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm
This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.
The Difference Between Clinical Trial Auditing And Monitoring
While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.
Learning About The Sensors In myMedidata
Learn how sensor data and advanced analytics can transform clinical research and enable your study to overcome data challenges, improving patient care.
Keeping Up With ClinOps: Why And How To Improve Delivery
Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
Digital Physical Activity Measures In Phase 3 Immunology Trials
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
Webinar: Reimbursement Methods For Sustainable CGT Business Models
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
Cohort Configuration Feature Of An RTSM Platform
Master trial agility by building and prioritizing cohorts in real time. Effortlessly manage dose levels and enrollment limits to keep your study on track, even as protocols evolve.
Perceptive eClinical
Learn about a randomization and trial supply management (RTSM) solution that helps keep your trial on track.
The Real Payoff Of Reusable IRT/RTSM System Design
By utilizing consistent, repeatable system builds, sponsors gain significant advantages during protocol amendments and operational changes.
Illuminating IHC: From Biomarker To Clinical Trial Assay
Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.
Effective Study Design And Execution Of Renal And Hepatic Impairment Trials
Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.
Why Disclosure Assessments Are The First Step To Improvement
Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.
Driving Simulation Studies At Altasciences
At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects.
What Is The Secret To Ongoing TMF Health?
Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.
Keeping Your Trials In Motion And Use AI Where It Makes Sense
Explore the "pinball" approach used by the Judi platform that is giving stakeholders a distinct competitive advantage in the clinical trial landscape.
End-To-End Clinical Data Flow
Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.
Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites
Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies...